To include your compound in the COVID-19 Resource Center, submit it here.

AN2728: Phase II started

Anacor began a double-blind, vehicle-controlled, Australian Phase II trial to evaluate topical 1%

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE